Rebranding as Hilo, the Swiss company will scale its “blood pressure intelligence” to the US this year, following expected FDA approval.
Via Lionel Reichardt / le Pharmageek
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Rebranding as Hilo, the Swiss company will scale its “blood pressure intelligence” to the US this year, following expected FDA approval.